Canopy Growth (CGC) Receivables - Net (2017 - 2026)
Canopy Growth (CGC) reported Receivables - Net of $26.5 million for Q1 2026, down 20.09% on a YoY basis from $33.1 million in Q1 2025, and up 27.23% sequentially from $20.8 million in Q4 2025.
Canopy Growth (CGC) Receivables - Net (2017 - 2026) Analysis & Trends
Canopy Growth (CGC) has 10 years of Receivables - Net data on file, last reported at $26.5 million in Q1 2026.
- For the quarter ending Q1 2026, Receivables - Net fell 20.09% year-over-year to $26.5 million; the trailing twelve-month figure through Mar 2026 stood at $26.5 million (down 20.09% YoY), and the FY2026 full-year result was $26.5 million, down 28.06% from the prior year.
- Receivables - Net grew to $26.5 million in Q1 2026, from $20.8 million in the prior quarter.
- In the past five years, Receivables - Net ranged from a high of $95.6 million in Q2 2023 to a low of $17.8 million in Q3 2025.
- A 5-year average of $43.7 million and a median of $38.5 million in 2024 frame the typical range for Receivables - Net.
- Across the five-year window, Receivables - Net soared 47.27% in 2023 and slumped 66.73% in 2024, its largest moves.
- Tracing CGC's Receivables - Net over 5 years: stood at $60.2 million in 2022, then declined by 21.97% to $47.0 million in 2023, then declined by 25.21% to $35.1 million in 2024, then sank by 40.77% to $20.8 million in 2025, then grew by 27.23% to $26.5 million in 2026.
- Business Quant data shows CGC's Receivables - Net at $26.5 million in Q1 2026, $20.8 million in Q4 2025, and $17.8 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Canopy Growth | 197.77 Mn | -68.15 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 26.46 Mn |
| Mar 31, 2026 | 26.46 Mn |
| Dec 31, 2025 | 20.80 Mn |
| Dec 31, 2025 | 20.80 Mn |
| Sep 30, 2025 | 17.84 Mn |
| Sep 30, 2025 | 17.84 Mn |
| Jun 30, 2025 | 36.11 Mn |
| Jun 30, 2025 | 36.11 Mn |
| Mar 31, 2025 | 33.11 Mn |
| Mar 31, 2025 | 33.11 Mn |
| Dec 31, 2024 | 35.12 Mn |
| Dec 31, 2024 | 35.12 Mn |
| Sep 30, 2024 | 26.77 Mn |
| Sep 30, 2024 | 26.77 Mn |
| Jun 30, 2024 | 31.81 Mn |
| Jun 30, 2024 | 31.81 Mn |
| Mar 31, 2024 | 38.48 Mn |
| Mar 31, 2024 | 38.48 Mn |
| Dec 31, 2023 | 46.95 Mn |
| Dec 31, 2023 | 46.95 Mn |